Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

Comment by MartialArtson Jan 22, 2018 10:05am
194 Views
Post# 27407405

RE:RE:RE:RE:RE:Looking like.....

RE:RE:RE:RE:RE:Looking like.....
ACB already has 450M shares issued.  CMED only has 24M.  Big difference.  CMED could do a 10/1 and still end up with about half the shares ACB has issued.

Doing a 18.5/1 would bring it to par and would allow novices to properly compare share prices.

It would be less $2 CMED compared fo $14 ACB and people would finally clue in how undervalued CMED is even at $40 trading on 24M shares.
<< Previous
Bullboard Posts
Next >>